Suppr超能文献

终身肥胖趋势与亚临床心肌损伤有关:特隆赫姆健康研究。

Lifetime obesity trends are associated with subclinical myocardial injury: The Trøndelag health study.

机构信息

Department of Cardiology, Akershus University Hospital, Lørenskog, Norway.

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

出版信息

J Intern Med. 2022 Mar;291(3):317-326. doi: 10.1111/joim.13391. Epub 2021 Oct 19.

Abstract

BACKGROUND

Obesity is associated with subclinical myocardial injury as quantified by concentrations of cardiac troponin T, but whether lifetime excess weight history is associated with increased concentrations of cardiac troponin I (cTnI) and how indices of abdominal adiposity and glycemic dysregulation affect these associations remain unclear.

METHODS

We analyzed cTnI with a high-sensitivity assay in 9739 participants in the Trøndelag Health (HUNT) Study at study visit 4 (2017-2019). BMI was assessed at study Visit 1 (1984-1986), 2 (1995-1997), 3 (2006-2008), and 4.

RESULTS

Median age at visit 4 was 68.7 years and 59% were women. Concentrations of cTnI were detectable in 84.1% of study participants, with a median of 2.5 (1.5-4.5 ng/L). We identified three clusters of BMI trajectories from visit 1 to 4, (1) stable normal weight, (2) stable overweight, and (3) stable obesity. Participants in clusters 2 and 3 were at increased risk of elevated concentrations of cTnI at visit 4 (odds ratio 1.27, 95% CI 1.09-1.47, and odds ratio 1.70, 95% CI 1.33-2.17, p for trend <0.001). Participants in cluster 3 had 22.0 (95% CI 14.1-29.9) higher concentrations of cTnI compared to participants in cluster 1 (p for trend <0.001). Dysregulated glucose metabolism and abdominal obesity did not influence our results.

CONCLUSIONS

Individuals with stable overweight or obesity are at increased risk of subclinical myocardial injury, independently of glycemic dysregulation and abdominal adiposity. Our data support a direct detrimental effect of long-standing obesity on cardiovascular health.

摘要

背景

肥胖与心脏肌钙蛋白 T 浓度量化的亚临床心肌损伤有关,但终生超重史是否与心脏肌钙蛋白 I(cTnI)浓度升高有关,以及腹部肥胖和血糖调节紊乱的指标如何影响这些关联尚不清楚。

方法

我们在特隆赫姆健康(HUNT)研究的 9739 名参与者中分析了第 4 次(2017-2019 年)的高敏 cTnI。BMI 在第 1 次(1984-1986 年)、2 次(1995-1997 年)、3 次(2006-2008 年)和 4 次就诊时进行评估。

结果

第 4 次就诊时的中位年龄为 68.7 岁,59%为女性。研究参与者中有 84.1%可检测到 cTnI 浓度,中位数为 2.5(1.5-4.5ng/L)。我们从第 1 次就诊到第 4 次就诊确定了三种 BMI 轨迹群,(1)稳定的正常体重,(2)稳定的超重,和(3)稳定的肥胖。处于群 2 和群 3 的参与者在第 4 次就诊时发生 cTnI 浓度升高的风险增加(优势比 1.27,95%置信区间 1.09-1.47,和优势比 1.70,95%置信区间 1.33-2.17,p 趋势<0.001)。与群 1 相比,群 3 的参与者的 cTnI 浓度高 22.0(95%置信区间 14.1-29.9)(p 趋势<0.001)。血糖调节紊乱和腹部肥胖并不能影响我们的结果。

结论

稳定超重或肥胖的个体发生亚临床心肌损伤的风险增加,与血糖调节紊乱和腹部肥胖无关。我们的数据支持长期肥胖对心血管健康的直接不良影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验